A milestone for Vaxxinova Autogenous Vaccines GmbH in Cuxhaven

Cuxhaven, DE, November 2, 2026 – We are proud to announce that our manufacturing site in Cuxhaven, Germany, has received Good Manufacturing Practice (EU GMP) certification from the German authorities.
The facility operates in accordance with article 1 (5) of Commission Implementing Regulation (EU) 2025/2091 for veterinary medicinal products, reinforcing our commitment to consistent quality and product excellence.
The confirmed scope covers the manufacture of veterinary vaccines/inactivated autogenous vaccines.

This milestone reflects the robust manufacturing and quality standards maintained at our Cuxhaven site.

For our team in Cuxhaven, the certification represents an important recognition of the dedication and expertise behind our manufacturing activities. A big thank you to everyone involved in reaching this milestone!
Vaxxinova supports the industry with tailor-made vaccines for poultry, cattle, swine and aquaculture around the globe. With autogenous vaccine facilities in Germany, Brazil, United States and South Africa we are experts in the field, providing fast and effective animal health solutions.

Quality in every step. Commitment to animal health.